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A B S T R A C T
The styrene oxide isomerase (SOI) represents a membrane-bound enzyme of the microbial styrene
degradation pathway and has been discussed as promising biocatalyst. It catalyzes the isomerization of
styrene oxide to phenylacetaldehyde. In this study a styC gene, which encodes the SOI of Rhodococcus
opacus 1CP, was optimized for optimal expression in Escherichia coli BL21(DE3) pLysS. The expression of
this synthetic styC was investigated and subsequently optimized. Highly active biomass was obtained
yielding an SOI activity of 44.5  8.7 U mg1 after 10 h. This represents the highest SOI activity reported
for crude cell extracts of SOI-containing bacterial strains. Remarkably, this biomass can be applied as
whole cell biocatalyst for the production of phenylacetic acids from styrene oxides. In the case of non-
substituted styrene oxide, nearly 730 mg l1 phenylacetic acid (85% yield) was formed over a period of
20 days.
ã2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Phenylacetaldehyde and phenylacetic acid represent ﬁne
chemicals with a high industrial demand. Both compounds are
used for the synthesis of pharmaceuticals, insecticides, disinfec-
tants, and products for the perfume industry [7,8,17,18,26,38].
Processes for industrial phenylacetaldehyde production are
established on two basic reactions: the oxidation of 2-phenylethanol
and the isomerization of styrene oxide [15]. For the oxidation of 2-
phenylethanol, hexavalent chromium compounds [24], silver(II)
picolinate[6],cationicrhodiumcomplexes[12],andN,N-dibromo-p-
toluenesulfonamide [39] have been reported to be useful catalysts.
The isomerization of styrene oxide can be catalyzed byacetic zeolite
[15], alkali-treated silica alumina [46], hydrotalcite-derived basic
solids [22], or titanium-containing synthetic zeolite [29] beside
others. Biotechnological processes of phenylacetaldehyde synthesis
have been described byseveralprevious studies, e.g., applying acell-
free styrene oxide isomerase (SOI) in presence of styrene oxide
[27,32,34] or whole cells of Gluconobacter or Acetobacter strains for
the transformation of 2-phenylethanol [5,28].
Phenylacetic acids are produced industrially by the hydrolysis
of phenylacetonitriles in presence of mineral acids at temperatures
of 80 C to 250 C [20]. Furthermore, the carbonylation of benzyl
chlorides catalyzed by tetracarbonyl nickel at 80 C and 10–60 bar
[2,4] leads to the formation of phenylacetic acids. Ruthenium(III)
EDTA complexes [43] or rhodium-based catalysts [14] are also used
to transform such benzyl halogenides. Some biochemical strategies
have been reported applying a nitrile hydratase (EC 4.2.1.84) and an
amidase (EC 3.5.1.4) of Rhodococcus equi TG328 [13] or an
arylacetonitrilase (EC 3.5.5.1) from Pseudomonas ﬂuorescens
EBC191 [42]. Koma et al. [23] have reported a further way to
obtain phenylacetic acid and 4-hydroxyphenylacetic acid from
glucose by a metabolically engineered Escherichia coli strain with
an expanded shikimate pathway.
Phenylacetaldehyde and phenylacetic acid have been found to
be intermediates of the microbiological styrene degradation via
side-chain oxidation [31]. This degradation route has been
reported for several bacteria, e.g., representatives of the genus
Pseudomonas [25,30,36,45], Rhodococcus [32,35,44], or Sphingo-
pyxis [35]. In order to establish a biotechnological process for the
synthesis of phenylacetaldehyde, previous investigations were
performed with styrene oxide isomerases (SOI, encoded by styC).
These enzymes are involved in the microbiological styrene
degradation and convert styrene oxide into phenylacetaldehyde
[16,19,27,31,32]. Despite of the high SOI activities in some wild-
type strains [35] the production of SOIs by these strains is very
time-consuming [34]. This aspect and the inhibition of these
enzymes by their product at higher concentrations [32,35] limits
their application and need further optimization.
The aim of the present study was the heterologous expression
of a synthetic styC gene in E. coli BL21(DE3) pLysS in order to
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improve the production of this biocatalyst for the enzymatic
synthesis of phenylacetaldehydes as well as to apply SOI-active
biomass for the whole-cell biotransformation of styrene oxides
into phenylacetic acids.
2. Material and methods
2.1. Chemicals and enzymes
All standard chemicals, substrates, non-substituted and substi-
tuted styrene oxides, and phenylacetic acids were purchased from
Sigma–Aldrich (Steinheim, Germany), Carl Roth (Karlsruhe,
Germany), AppliChem (Darmstadt, Deutschland), FLUKA (Buchs,
Switzerland), and TCI Deutschland GmbH (Eschborn, Germany).
Enzymes, related buffers, vectors, and kits were purchased from
Thermo Fisher Scientiﬁc (Waltham, USA), Invitrogen (Carlsbad,
USA), Novagene (Darmstadt, Germany), and Jena Bioscience (Jena,
Germany).
2.2. Plasmids and bacterial strains
The genetic information of the native styC gene encoding a
styrene oxide isomerase in Rhodococcus opacus 1CP has recently
been reported by a former study [35]. During present study, a
synthetic gene was constructed by gene synthesis encoding StyC
from strain 1CP. To that end, the native gene styC was optimized for
expression by rewriting the codon usage of R. opacus 1CP into that
of Acinetobacter baylii ADP1 by the OPTIMIZER online tool [37]. This
codon usage was used because to our experience it is also
applicable for the protein expression in E. coli strains and further
hosts (data not shown). Additionally, NotI, KpnI, EcoRI, and NcoI
restriction sites were appended at both ends of the gene to
facilitate its cloning into various expression vectors. The gene
sequence constructed (Supplemental Fig. S1) was subsequently
synthesized by MWG Euroﬁns Operon (Ebersberg, Germany) and
provided in the cloning vector pEX-A.
The synthetic gene styC was ligated into the expression vector
pET16bP (pET16b [Novagene] with altered multicloning site, U.
Wehmeier, personal communication) and the construct subse-
quently transformed into E. coli DH5a and ﬁnally into E. coli BL21
(DE3) pLysS as described below in detail.
The pEX-A-styC construct was transferred into E. coli DH5a via
heat–shock transformation for propagation. Afterwards, plasmid
DNA was puriﬁed by the Gene JET Plasmid Miniprep Kit (Thermo
Scientiﬁc). 0.5 mg pEX-A-styC and 0.3 mg pET16bP were digested in
1  buffer O containing 12 units (U) of the enzyme NcoI and 3 U of
NotI (Thermo Scientiﬁc). The DNA was incubated for 4 h at 37 C.
Subsequently, the products were puriﬁed by gel electrophoresis
(1% agarose, 90 V), stained with SYBR Gold (Invitrogen), and
isolated from the gel by the DNA Isolation Spin Kit (AppliChem).
Afterwards, 6 ng of the styC-containing insert and 16 ng digested
pET16bP (molar ratio 4:1) were ligated in 1  T4 ligase buffer
containing 1 U of T4 ligase (Thermo Scientiﬁc). After a 30 min
incubation at 22 C, ligation product was immediately used for the
transformation in strain DH5a as described above. After propaga-
tion of the construct pET16bP-styC, DNAwas puriﬁed bythe GeneJET
Plasmid Miniprep Kit. The transformation of puriﬁed DNA into E. coli
BL21(DE3) pLysS was also performed as described above.
Clones harboring the synthetic gene styC have been designated
as E. coli BL21(DE3) pLysS pET16bP-styC. Biomass was initially
investigated for SOI activity by a pre-incubation of the cells in
100 ml bafﬂed ﬂasks containing 10 ml of LB medium (pH 7, 5 g l1
NaCl [40]) at 37 C. Cells were grown up to an optical density at
600 nm (OD600) of about 1. Afterwards, cultures were induced by
addition of 0.5 mM IPTG, cultivated for 20–22 h at 22 C, and the
cells subsequently disrupted and screened for SOI activity as
described below. Quite high IPTG concentrations of 0.5 mM were
used during all experiments to ensure complete styC induction in
all cells.
2.3. Optimization of the SOI expression in E. coli BL21(DE3) pLysS
LB broth was used to cultivate E. coli BL21(DE3) pLysS pET16bP-
styC. If not stated otherwise, 100 mg ml1 ampicillin and 50 mg
ml1 chloramphenicol were additionally added to the culture
medium.
Expression of styC in E. coli BL21(DE3) pLysS pET16bP-styC was
investigated with respect to pH, temperature, NaCl concentration,
the presence of antibiotics, the inﬂuence of glucose, and the effect
of a pre-incubation at different temperatures before gene
expression. For that, the precultures were incubated at 30 C for
17–19 h at 120 rpm in 1 l bafﬂed ﬂasks containing LB medium (pH 7,
5 g l1 NaCl). These cultures were harvested by centrifugation
(15 min, 3000  g), once washed with 10–15 ml of 25 mM
phosphate buffer (pH 7), and the pellets resuspended and diluted
with fresh LB medium to adjust an OD600 of 0.7. Expression in LB
medium (5 g l1 NaCl) with pH values of 6, 7, and 8 was initially
investigated at 25 C to evaluate the optimal (best) pH for
subsequent experiments. Afterwards, the inﬂuence of the expres-
sion temperature on SOI activity at 14 C, 30 C, and 37 C was
investigated applying LB medium (pH 7) with 5 g l1 NaCl.
Furthermore, the effect of the NaCl concentration on styC
expression was determined using LB medium (pH 7) with either
5 g l1 or 10 g l1 NaCl at 30 C. The effect of antibiotics on the SOI
gene expression at 30 C was investigated by a cultivation of
biomass in LB medium (pH 7, 10 g l1 NaCl) with and without
ampicillin and chloramphenicol. The inﬂuence of in total 20 mM
glucose (added in 10 mM-portions during enzyme expression) on
the SOI activity was determined in LB medium (pH 7, 5 g l1 NaCl)
at 30 C. Furthermore, the effect of a one-step cultivation (initial
biomass growth and subsequent expression at 30 C) or a two-step
cultivation (initial biomass growth at 37 C, expression at 30 C)
was investigated applying LB medium (pH 7) with 5 g l1 NaCl. In
all cases the cultivation was performed in 250 ml or 500 ml bafﬂed
ﬂasks containing 25 ml or 50 ml of liquid medium. SOI gene
expression was induced by addition of IPTG in a ﬁnal concentration
of 0.5 mM.
Up-scaling of the biomass production under more deﬁned
conditions was performed by fed-batch cultivation of E. coli BL21
(DE3) pLysS pET16bP-styC in a 5 l biofermenter (ED/ES5; B. Braun
Biotech AG, Melsungen, Germany). For that purpose, 4 l of LB broth
(pH 7, 5 g l1 NaCl) were used as culture medium. Precultures were
incubated as described above and used to inoculate the fermenter.
An initial OD600 of 0.05 was adjusted. Afterwards, the culture was
incubated at 37 C, 300–400 rpm, and with an aeration of
6 standard liters per min (slpm) for about 4 h to obtain biomass
with an OD600 of about 1.4. The expression of styC was
subsequently induced by addition of IPTG in a ﬁnal concentration
of 0.5 mM. During the expression of styC, biomass was incubated at
30 C, 400–500 rpm, and with 6 slpm for several days. Additionally,
in total 15 mM glucose were added in 5 mM portions. To follow the
growth of the culture and the expression of styC after addition of
IPTG, the culture was frequently sampled to determine OD600,
speciﬁc SOI activity, and cell dry weight.
2.4. Applicability of E. coli BL12(DE3) pLysS pET16bP-styC as whole-
cell biocatalyst
ToinvestigatetheapplicabilityofE.coliBL21(DE3)pLysSpET16bP-
styC for the transformation of styrene oxide, SOI-active biomass was
obtained from cultures incubated in ﬂasks or in the fermenter under
conditions as described above. 6–24 h after addition of IPTG, 50–
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400 ml culture samples were harvested bycentrifugation (5000  g,
15 min, 10 C), the cells were washed once with 25 mM phosphate
buffer (pH 7.0), and centrifuged again. The pellet was subsequently
resuspended in 50–400 ml fresh 25 mM phosphate buffer (pH 7.0)
and distributed to bafﬂed ﬂasks. These suspensions were immedi-
ately used for biotransformation experiments.
For the biotransformation of styrene oxide either 15 ml or
200 ml SOI-active biomass were incubated in 250 ml or 1 l bafﬂed
ﬂasks with in total 63 or 600 mmol styrene oxide which were
added in portions of 7.9 mmol or 200 mmol (initially correspond to
0.5–1 mM in the medium) over 19–20 days. The cultures were
ventilated all 2–3 days for 1–4 h. Samples were regularly taken
from the cultures and the product formation quantiﬁed by
reversed-phase high-performance liquid chromatography (re-
versed-phase HPLC) as described below.
To determine the substrate spectrum, 10 mmol of one of the
following compounds were added to 250 ml ﬂasks containing
25 ml cell suspension: styrene oxide, 4-ﬂuorostyrene oxide, 4-
chlorostyrene oxide, or 4-bromostyrene oxide. Substrate forma-
tion was monitored by reversed-phase HPLC.
2.5. Enzyme assays and protein quantiﬁcation
The SOI activity was measured in units (U) and one unit is deﬁned
as the amount of SOI which converts 1 mmol styrene oxide to
phenylacetaldehyde per min at 21–22 C. For that purpose, 1.5 ml
samples were taken from the expression cultures and subsequently
centrifuged (13,000  g, 5 min). Each cell pellet obtained was
suspended in 500 ml 25 mM phosphate buffer (pH 7) and 500 mg
zirconia beads as well as 8 U DNAse were added. The batches were
vigorously shaken for 30 min at 30 Hz in a swing mill (MM-200,
Retsch, Germany). The extracts were subsequently analyzed for SOI
activity by incubation with styrene oxide and sampling as well as
Fig. 1. Inﬂuence of different parameters on the styC expression in E. coli BL21(DE3) pLysS pET16bP-styC. The data presented illustrates: the inﬂuence of different pH values (6,
7, and 8) in the culture medium on (a) bacterial growth and (b) expression of active SOI; the inﬂuence of different cultivation temperatures (14, 25, 30, or 37 C) on (c) growth
and (d) expression; the inﬂuence of NaCl (5 or 10 g l1) on (e) growth and (f) expression. The cultivation was performed in bafﬂed ﬂasks at 120 rpm for 24–72 h. Further
incubation conditions for each experiment are described in the Material and Methods section. Protein expression was induced by addition of 0.5 mM IPTG. Data points
represent the means of four or six independent measurements and the standard deviations are given.
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quenching with H3PO4as previously described [32]. Afterwards, the
acidiﬁed samples were directly used for reversed-phase HPLC [35].
To detect products formed by whole-cell biotransformation,
500 ml of the culture medium was sampled and diluted with an
equal volume of methanol. The mixture was shaken for 1 min,
centrifuged (5 min, 13,000  g), and supernatant analyzed by
reversed-phase HPLC. HPLC analysis was performed as previously
described [33] applying a mobile phase containing 50% methanol
(v/v) and 0.1% (w/v) phosphoric acid at a ﬂow rate of 0.7 ml min1.
For the determination of the protein concentration, the method
established by Bradford [3] was performed.
3. Results and discussion
3.1. Determination of conditions suitable for the improved SOI
expression in E. coli BL21(DE3) pLysS
For the expression of styC in strain BL21(DE3) pLysS pET16bP-
styC, no signiﬁcant inﬂuence of pH 6–8 was observed in the present
study (Fig. 1a and b). In all cases the highest SOI activities were
measured about 4–5 h after addition of the inducer IPTG (pH 6:
24.4  8.6 U mg1; pH 7: 32.1 16.9 U mg1; pH 8: 28.9  11.2 U
mg1). However, the decrease of the enzyme activity was found to
be lower under neutral conditions (pH 7) than under the other
conditions. Thus, a pH of 7 was considered for all subsequent
experiments.
In a second step, the cultivation temperature was investigated
for its inﬂuence on SOI gene expression after addition of the
inducer IPTG. With respect to the temperature the cell densities
reached showed larger differences (Fig. 1c). The highest OD600
values of about 4 and 3 were reached at 25 C and 30 C. The highest
SOI activities were measured 4–5 h after addition of IPTG (Fig. 1d).
A speciﬁc SOI activity of 37.9  17.4 U mg1 was reached at 30 C
and only marginally lower speciﬁc activities of 31–32 U mg1 were
observed after incubation at 37 C or 25 C. The expression of styC
at 14 C resulted only in a low SOI activity of 7.1  2.5 U mg1. This
indicates that SOI activity of E. coli BL21(DE3) pLysS pET16bP-styC
can obviously not be enhanced by slowering transcription and
translation rate by lowering the cultivation temperature as
observed for other proteins [1,10,11,41].
Additionally, the NaCl concentration of the medium was varied
in order to investigate the inﬂuence of osmolarity on protein
production (Fig. 1e and f). Expression of styC in the presence of
medium containing 5 g l1 NaCl led to the formation of less
biomass with higher SOI activity (OD600 of 2.8 reached after 23 h;
maximum SOI activity of 37.9  17.4 U mg1 after 4 h) compared to
LB medium containing 10 g l1 (OD600 of 3.3 reached after 23 h,
maximum SOI activity of 28.8  15.0 U mg1 after 4 h). Thus, the
lower concentration was preferred for further investigations.
Furthermore, it was observed that the antibiotics ampicillin and
chloramphenicol have no signiﬁcant effect on the expression and the
highest activities were also reached about 4 h after addition of IPTG
(with antibiotics: 28.8  15.1 U mg1; without antibiotics:
32.7  15.7 U mg1). Initial cultivation of E. coli BL21(DE3) pLysS at
37 C and subsequent induction of the biomass with IPTG at 30 C
did not affect the SOI activity (maximum SOI activity of 24.7  10.1
U mg1) negatively compared to a one-step cultivation at a constant
temperature of 30 C (maximum SOI activity of 26.3  8.3 U mg1).
In both cases the highest SOI activities were reached about 4 h after
addition of IPTG. But the two-step cultivation allowed a faster
growth during the ﬁrst step of cultivationwhilst IPTG was not added
(data not shown). Furthermore, the addition of glucose in portions
of 10 mM (in total 20 mM within 5 h) did not inﬂuence the SOI gene
expression and the activity (data not shown). Based on these
preliminary experiments, an up-scaled cultivation in a fermenter
was performed.
3.2. Up-scaled production of biomass with high SOI activity
The cultivation of strain BL21(DE3) pLysS pET16bP-styC was
performed in the fermenter under optimal conditions for SOI
expression (30 C, LB medium with pH 7 and 5 g l1 NaCl) (Fig. 2).
The fermenter cultivation enabled an improved reproducibility of
the cultivation as well as the production of larger amounts of SOI-
active biomass.
The highest SOI activity of 44.5  8.7 U mg1 was determined
about 6 h after addition of ITPG (Fig. 2) which is also similar to the
preliminary experiments mentioned above (Fig. 1). This recombi-
nant speciﬁc activity corresponds to our knowledge to the highest
SOI activity ever reported for crude cell extracts of SOI-containing
wild-type strains [16,19,30,34,35]. In contrast to the cultivation in
battled ﬂasks, culture volume was signiﬁcantly extended from
25 ml to 4 l. Thus, in total 2380 mg  262 mg protein and
106,100  9200 U of SOI were obtained after in total 10 h applying
strain BL21(DE3) pLysS pET16bP-styC in the fermenter. A previous
study has reported the production of a wild-type SOI in R. opacus
1CP [34]. The cultivation of strain 1CP was performed in the same
fermenter containing also 4 l of medium. In the former study, a
total SOI activity of 18,000 U and in total about 1000 mg protein
were obtained which corresponds to a speciﬁc SOI activity of only
18 U mg1 [34]. Furthermore, the cultivation time of this Rhodo-
coccus strain was signiﬁcantly longer and the production of active
biomass needed 28 days. In summary, the recombinant production
of the SOI improved the speciﬁc enzyme activity by the factor
2.5 and reduced the cultivation time by a factor of 67 compared to
the application of the wild-type strain 1CP. The recombinant SOI
obtained can be applied for the cell-free production of phenyl-
acetaldehyde from styrene oxide as described previously
[27,32,34].
3.3. Applicability of E. coli BL21(DE3) pLysS pET16bP-styC as whole-
cell biocatalyst for the production of phenylacetic acid
E. coli BL21(DE3) pLysS pET16bP, which only contained the
pET16bP-vector without styC, served as negative control for the
whole-cell biotransformation of styrene oxide. No product
formation was observed in this case (data not shown). The
integration of an SOI in E. coli BL21(DE3) pLysS pET16bP-styC
enables whole cells to transform styrene oxide via
Fig. 2. Expression of SOI activity in E. coli BL21(DE3) pLysS pET16bP-styC during
cultivation in the bioreactor. 4 l of biomass were cultivated at 37 C for 4 h during
which an OD600 of 1.4 was reached. Afterwards, cultivation temperature was
decreased to 30 C and 0.5 mM ITPG were added to express the synthetic styC. The
ﬁgure illustrates the development of the SOI activity in the E. coli cells and of two
growth parameters (OD600, dry weight) after addition of IPTG. Portions of 5 mM
glucose were additionally added one, four, and 5 h after addition of ITPG. The data
illustrated represent the averages of two or three independent measurements and
the standard deviations are given.
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phenylacetaldehyde to phenylacetic acid (Figs. 3 and 4). The latter
reaction is commonly catalyzed by phenylacetaldehyde dehydro-
genases (PAD). A gene encoding such an aldehyde dehydrogenase
(NCBI Acc. no. ACT43241) has also been found on the genome of E.
coli BL21 (Acc. no. CP001509) in previous studies Jeong et al., 2009;
[47]. Further metabolization of phenylacetic acid was not observed
which is in accordance with the fact that corresponding genes,
which are involved in the further degradation of phenylacetic acid
[9], are not present on the genome of strain BL21.
Preliminary results showed that a high phenylacetaldehyde
concentration of about 1.35 mM (162 mg l1), which was formed
after addition of three 1 mM portions of styrene oxide within 30 h,
caused an irreversibly reduced metabolic activity in E. coli BL21(DE3)
pLysS pET16bP-styC and prevented the formation of higher amounts
of phenylacetic acid (Fig. 3). Such a toxic effect of phenyl-
acetaldehyde in similar concentration of 1.3 mM (156 mg l1)
has also been reported by Kang et al. [21].
To prevent the inactivation of the biomass, a less frequent
addition of styrene oxide was performed in ﬁnal concentrations of
0.5–1.3 mM each 2–4 days (Fig. 4). The application of 15 ml of SOI-
active biomass of E. coli BL21(DE3) pLysS pET16bP-styC
(14.3  4.3 U mg1 SOI activity, OD600 2.9, 1.36 mgcell dry weight
ml1, cells resuspended in phosphate puffer [25 mM, pH 7]) resulted
in 3.32  0.42 mM phenylacetic acid (452  57 mg l1) after 15 days
which corresponds to a yield of 79.6% (Fig. 4). After this period, 4.3%
of 2-phenylethanol (0.18  0.01 mM, 2.0  1.2 mg l1) and 13.7%
phenylacetaldehyde (0.57  0.13 mM, 68.5 15.6 mg l1) were
present. After 20 days, the following yields were obtained: 85.4%
for phenylacetic acid (5.36  0.85 mM, 729  116 mg l1) and 2.5%
for 2-phenylethanol (0.16  0.04 mM, 19.5  4.9 mg l1). These
results indicate that phenylacetic acid is formed as the main
product. Additionally, the results described above also conﬁrmed
that the biomass still possesses SOI activity after 20 days despite of
the absence of IPTG during the biotransformation.
3.4. Applicability of E. coli BL21(DE3) pLysS pET16bP-styC for the
production of substituted phenylacetic acids by whole-cell
biotransformation
E. coli BL21(DE3) pLysS pET16bP-styC was also applied for the
transformation of mono-halogenated styrene oxides. For that,
25 ml biomass (OD600 of 1.8, 0.85 mgcell dry weightml1) with a
speciﬁc SOI activity of 19.6  6 U mg1 were incubated with
10 mmol non-substituted or substituted styrene oxide. Beside
the phenylacetic acids, also the corresponding phenylacetalde-
hydes and phenylethanols were determined during the ﬁrst hours
in all cases. Amounts of 6.2 mmol, 3.6 mmol, and 3.1 mmol were
obtained for phenylacetic acid, 4-bromophenylacetic acid, and
4-ﬂuorophenylacetic acid after 75 min, respectively. A lower yield
of 2.3 mmol was achieved in the case of 4-chlorophenylacetic acid.
Further cultivation without addition of fresh substrate led to the
complete transformation of the respective substrates and formed
aldehydes to the corresponding phenylacetic acids. Besides small
amounts of the corresponding phenylethanols, the substrates
styrene oxide and 4-bromostyrene oxide were transformed
completely to the corresponding acids after 150 min while
4-chlorostyrene oxide was completely metabolized to 4-chlor-
ophenylacetic acid after 360 min. Remarkably, the transformation
of 4-ﬂuorostyrene oxide occurred somewhat slower, but was also
completed in 24 h.
4. Conclusion
A promising biocatalyst was constructed by using E. coli BL21
(DE3) pLysS as host for the heterologous expression of a synthetic
SOI gene (styC) which encodes the SOI of R. opacus 1CP. An
expression temperature of 30 C and LB medium with a pH of 7 and
5 g l1 NaCl were suitable to obtain biomass with a speciﬁc SOI
activity of up to 44.5  8.7 U mg1 within 6 h after addition of IPTG.
The recombinant biomass provides a promising source for the
preparation and enrichment of the SOI for cell-free applications
[32,34]. E. coli BL21(DE3) pLysS pET16bP-styC was found to be
additionally suitable as whole-cell biocatalyst for the production of
(substituted) phenylacetic acids from corresponding styrene oxide
(s). In the case of phenylacetic acid, a product amount of about
730 mg l1 (85% yield) was reached within 20 days.
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Fig. 3. Inhibition of the whole-cell biocatalyst by rapid production of phenylace-
taldehyde after a too frequent addition of styrene oxide. 200 ml biomass of E. coli
BL21(DE3) pLysS pET16bP-styC (OD600 2.3, 1.08 mgcell dry weightml1, speciﬁc SOI
activity of 19.7  5.7 U mg1) were cultured for 19 days (444 h). Within the ﬁrst 36 h,
in total 0.6 mmol styrene oxide were added in portions of 0.2 mmol. Afterwards, the
biomass was cultured without further addition of styrene oxide. Formation of
phenylacetic acid, 2-phenylethanol, and phenylacetaldehyde is illustrated. Data
points represent the means of four independent measurements and the standard
deviations are given.
Fig. 4. Whole-cell biotransformation of styrene oxide applying E. coli BL21(DE3)
pLysS pET16bP-styC. 15 ml of E. coli BL21(DE3) pLysS pET16bP-styC (OD600 2.9,
1.36 mgcell dry weightml1, speciﬁc SOI activity of 14.3  4.3 U mg1) in 25 mM
phosphate buffer (pH 7) were cultivated over 20 days. Within the cultivation time in
total about 63 mmol styrene oxide were added in portions of about 7.9 mmol.
Formation of phenylacetic acid, 2-phenylethanol, and phenylacetaldehyde is
illustrated. Data points represent the means of two independent measurements
and the standard deviations are given.
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